MannKind Corp. CEO Discloses Buying 700K Shares

In a Form 4 filing with the SEC, CEO, 10% Owner of MannKind Corp. (MNKD), discloses buying 700,000 shares of  MNKD on 01/12/2011 at an average price of $8.71 p/sh for a total of $2,800,000.

MannKind Corp has a market cap of $1.12 billion; its shares were trading during Wednesday afternoon trading at around $9.01 with a PEG ratio of (0.10).

Mankind is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer. The co. was founded in 1991 and is based in Valencia, California.

About Ron Haruni 1044 Articles
Ron Haruni is the Co-Founder & Editor in Chief of Wall Street Pit.

Be the first to comment

Leave a Reply

Your email address will not be published.